181 related articles for article (PubMed ID: 33747205)
21. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Petridis C; Arora I; Shah V; Megalios A; Moss C; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
Breast Cancer Res; 2019 May; 21(1):58. PubMed ID: 31060593
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
23. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.
Hall J; Marcel V; Bolin C; Fernet M; Tartier L; Vaslin L; Hainaut P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):527-33. PubMed ID: 19442246
[TBL] [Abstract][Full Text] [Related]
24. Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
Kleiblová P; Stolařová L; Křížová K; Lhota F; Hojný J; Zemánková P; Havránek O; Vočka M; Černá M; Lhotová K; Borecká M; Janatová M; Soukupová J; Ševčík J; Zimovjanová M; Kotlas J; Panczak A; Veselá K; Červenková J; Schneiderová M; Burócziová M; Burdová K; Stránecký V; Foretová L; Macháčková E; Tavandzis S; Kmoch S; Macůrek L; Kleibl Z
Klin Onkol; 2019; 32(Supplementum2):36-50. PubMed ID: 31409080
[TBL] [Abstract][Full Text] [Related]
25. Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas.
Gao Y; Ling C; Ma X; Wang H; Cui Y; Nie M; Tong A
Int J Endocrinol; 2021; 2021():1392386. PubMed ID: 34630562
[TBL] [Abstract][Full Text] [Related]
26. Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer.
LaPelusa M; Shen C; Gillaspie EA; Cann C; Lambright E; Chakravarthy AB; Gibson MK; Eng C
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892891
[TBL] [Abstract][Full Text] [Related]
27. Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations.
Manoukian S; Peissel B; Frigerio S; Lecis D; Bartkova J; Roversi G; Radice P; Bartek J; Delia D
Breast Cancer Res Treat; 2011 Nov; 130(1):207-15. PubMed ID: 21562711
[TBL] [Abstract][Full Text] [Related]
28. Role of p53 in the progression of gastric cancer.
Busuttil RA; Zapparoli GV; Haupt S; Fennell C; Wong SQ; Pang JM; Takeno EA; Mitchell C; Di Costanzo N; Fox S; Haupt Y; Dobrovic A; Boussioutas A
Oncotarget; 2014 Dec; 5(23):12016-26. PubMed ID: 25427447
[TBL] [Abstract][Full Text] [Related]
29. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
Vahteristo P; Bartkova J; Eerola H; Syrjäkoski K; Ojala S; Kilpivaara O; Tamminen A; Kononen J; Aittomäki K; Heikkilä P; Holli K; Blomqvist C; Bartek J; Kallioniemi OP; Nevanlinna H
Am J Hum Genet; 2002 Aug; 71(2):432-8. PubMed ID: 12094328
[TBL] [Abstract][Full Text] [Related]
30. Associations between mutations of the cell cycle checkpoint kinase 2 gene and gastric carcinogenesis.
Hong Y; Shi J; Ge Z; Wu H
Mol Med Rep; 2017 Oct; 16(4):4287-4292. PubMed ID: 29067458
[TBL] [Abstract][Full Text] [Related]
31. Association of
Xu W; Liu D; Yang Y; Ding X; Sun Y; Zhang B; Xu J; Su B
J Thorac Dis; 2016 Sep; 8(9):2519-2529. PubMed ID: 27747004
[TBL] [Abstract][Full Text] [Related]
32. Characterization of CHEK2 mutations in prostate cancer.
Wu X; Dong X; Liu W; Chen J
Hum Mutat; 2006 Aug; 27(8):742-7. PubMed ID: 16835864
[TBL] [Abstract][Full Text] [Related]
33. Current perspectives on CHEK2 mutations in breast cancer.
Apostolou P; Papasotiriou I
Breast Cancer (Dove Med Press); 2017; 9():331-335. PubMed ID: 28553140
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
Zhou J; Zhao Z; Zhang Y; Bao C; Cui L; Cai S; Bai Y; Shen L; Zhang X
Oncology; 2020; 98(8):583-588. PubMed ID: 32521533
[TBL] [Abstract][Full Text] [Related]
35. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
Adamsen BL; Kravik KL; De Angelis PM
Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
[TBL] [Abstract][Full Text] [Related]
36. Alternative splicing and mutation status of CHEK2 in stage III breast cancer.
Staalesen V; Falck J; Geisler S; Bartkova J; Børresen-Dale AL; Lukas J; Lillehaug JR; Bartek J; Lønning PE
Oncogene; 2004 Nov; 23(52):8535-44. PubMed ID: 15361853
[TBL] [Abstract][Full Text] [Related]
37. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Domagala P; Wokolorczyk D; Cybulski C; Huzarski T; Lubinski J; Domagala W
Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879
[TBL] [Abstract][Full Text] [Related]
38. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
Siddiqui R; Onel K; Facio F; Nafa K; Diaz LR; Kauff N; Huang H; Robson M; Ellis N; Offit K
Fam Cancer; 2005; 4(2):177-81. PubMed ID: 15951970
[TBL] [Abstract][Full Text] [Related]
39. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
[TBL] [Abstract][Full Text] [Related]
40. A novel CHEK2 variant identified by next generation sequencing in an Indian family with hereditary breast cancer syndrome.
Bhai P; Saxena R; Kulshrestha S; Verma IC
Cancer Genet; 2019 Jun; 235-236():13-17. PubMed ID: 31296309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
